In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Premature infants who are placed on initial empirical antibiotic therapy for 5 days or longer are at increased risk for late-onset sepsis, necrotizing…
NEW YORK (Reuters Health) – A meta-analysis of existing evidence confirms that alpha-blocker treatment reduces pain and urinary symptoms and improves quality of life in patients with indwelling…
Brien Smith, MD, Board Chair, Epilepsy Foundation, discusses his lifelong struggle with epilepsy and his rise to becoming Chief of Neurology for the Spectrum Health Medical Group and…
NEW YORK (Reuters Health) – There is no need to interrupt antiplatelet therapy before tooth extractions, as long as appropriate local hemostatic measures are taken, according to results…
NEW YORK (Reuters Health) – Pooled data suggest that cancer patients who are treated with sunitinib (Sutent; Pfizer) have about a 2-fold increased relative risk of developing high-grade…
NEW YORK (Reuters Health) – In hemodynamically stable preterm infants, there seems to be minimal clinical benefit to giving a single dose of furosemide right before packed red…
NEW YORK (Reuters Health) – Nearly 1 in 5 cancer patients treated with cisplatin-based chemotherapy have a thromboembolic event within a month of ending treatment, according to a…
NEW YORK (Reuters Health) – A combination of drugs designed to prevent pain, distress and physiologic instability in premature infants being intubated works better than premedication with morphine,…
NEW YORK (Reuters Health) – For patients with Alzheimer’s disease, prophylactic treatment with divalproex sodium does not delay the emergence of agitation or psychosis, or slow the progression…
Anthony Geraci, MD, Founder and President, neurOasis, provides an overview of the various treatments for migraine, including a class of medication called triptans and a new drug technology…